Bayer announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for sevabertinib, an oral, targeted HER2 tyrosine kinase inhibitor (TKI), as a first-line treatment for...
Private equity firm ChrysCapital is all set to acquire a strategic stake in Linux Laboratories, a Chennai-based specialty pharmaceutical company focused on central nervous...
In a major breakthrough for affordable oncology care, Pinnacle Life Science Pvt. Ltd., a subsidiary of Aarti Drugs, has officially launched Venetoclax in India. With this milestone, Pinnacle becomes the...
Union Minister Piyush Goyal held a high-level meeting with a delegation from the All India Organisation of Chemists & Druggists (AIOCD), led by President Shri J. S. Shinde,...
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has invited public feedback on a growing industry practice: pharmaceutical companies marketing several distinct...
In a critical move toward sharpening drug safety and regulatory clarity, the misuse and proliferation of "brand name extensions" within the pharmaceutical sector has...
In a proactive effort to combat rising oncology rates, Sindhu Hospitals,a newly inaugurated, state-of-the-art, 1,500-bed comprehensive cancer care institution has announced the launch of a widespread community...
In a major step toward realizing its ambitious “Telangana Rising 2047” vision, the Government of Telangana has officially released the draft **Telangana Core Urban...